-sodium and meglumine diatrizoate solutions for intravenous x-ray examinations

Although ionic contrast agents have been largely replaced by marginally safer non-ionic products, some niche applications remain. Further, the role of ionics is being re-evaluated in the light of their substantially lower prices and hence their superior cost/benefit profile.

Our product range are based on diatrizoic acid and are generically similar to the Schering AG offerings, with four different formulas indicated for urography, angiography, IVP to name a few.

The product range is registered for sale in Australia, and we believe that extending this permission to the USA under the FDA's "grandfathering" provisions would be a simple form-filling exercise. The technology is available for license.